HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gareth Shackleton Selected Research

thioxanthone

2/2009A phase I dose-escalation study of SR271425, an intravenously dosed thioxanthone analog, administered weekly in patients with refractory solid tumors.
8/2008Phase I dose-escalation study of the thioxanthone SR271425 administered intravenously once every 3 weeks in patients with advanced malignancies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gareth Shackleton Research Topics

Disease

2Neoplasms (Cancer)
02/2009 - 08/2008
1Cardiotoxicity
08/2008

Drug/Important Bio-Agent (IBA)

2SR 271425IBA
02/2009 - 08/2008
2thioxanthoneIBA
02/2009 - 08/2008
1WIN 33377IBA
08/2008